Cannabis Legalization World Map

This originally appeared at https://www.cannabisbusinesstimes.com/article/cannabis-legalization-world-map/ Argentina – Status: CBD legalized/Partially medically legalized/Decriminalized Medical cannabis has been legal in Chubut and Santa Fe Provinces since late 2016. In March, the Argentinian senate legalized cannabidiol (CBD) oil for treatment of certain conditions, including epilepsy. The national medical authorities are the only group allowed to produce and distribute […]

Summary of international legal frameworks for Cannabis

Implications of adult-use legalisation for compliance with international law The central basis for international control of the movement of cannabis around the globe is the 1961 UN Single Convention on Narcotics (the “Single Convention”), which is enforced by the International Narcotics Control Board (the “INCB”). The key provisions are as follows: Regarding Article 36, ‘possession’ […]

Cornerstone paper of the federal government (of germany) on the introduction of a controlled dispensing of cannabis to adults for the purpose of recreation

In the 2021 coalition agreement, the coalition parties agreed to introduce controlled dispensing of cannabis to adults in licensed shops. of cannabis to adults for consumption purposes in licensed stores. This is intended to control the quality, prevent the transfer of contaminated substances and improve the protection of minors and the health of consumers.protection of […]

Guide To Cannabis in Europe

Austria Austria’s marijuana laws are complicated but more tolerant than a number of countries on the continent. Reforms went into effect in 2016 that decriminalized possession of small quantities of cannabis for personal use. In 2008, cannabis byproducts for medicinal use (CBPMs) were legalized through an amendment to the Narcotic Substances Act. That said, access […]

Recreational cannabis legalization has had limited effects on a wide range of adult psychiatric and psychosocial outcomes

This originally appeared at https://www.cambridge.org/core/journals/psychological-medicine/article/recreational-cannabis-legalization-has-had-limited-effects-on-a-wide-range-of-adult-psychiatric-and-psychosocial-outcomes/D4AB5EB78D588473A054877E05D45F16 Published online by Cambridge University Press:  05 January 2023 Stephanie M. Zellers[Opens in a new window],J. Megan Ross,Gretchen R. B. Saunders,Jarrod M. Ellingson,Tasha Walvig, Jacob E. Anderson,Robin P. Corley,William Iacono,John K. Hewitt,Christian J. Hopfer,Matt K. McGue and Scott Vrieze Abstract Background The causal impacts of recreational cannabis legalization are not well […]

Associations between adolescent cannabis use and neuropsychological decline: a longitudinal co-twin control study

This originally appeared at https://onlinelibrary.wiley.com/doi/abs/10.1111/add.13946 Madeline H. Meier, Avshalom Caspi, Andrea Danese, Helen L. Fisher, Renate Houts, Louise Arseneault, Terrie E. Moffitt First published: 22 July 2017 https://doi.org/10.1111/add.13946 Abstract Aims This study tested whether adolescents who used cannabis or met criteria for cannabis dependence showed neuropsychological impairment prior to cannabis initiation and neuropsychological decline from before to after cannabis initiation. Design […]

Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain

This originally appeared at https://pubmed.ncbi.nlm.nih.gov/36598058/ Evaluating the impact of cannabinoids on sleep health and pain in patients with chronic neuropathic pain: a systematic review and meta-analysis of randomized controlled trials Aidan Leonard McParland  1 , Anuj Bhatia  2   3 , John Matelski  4 , Chenchen Tian  3 , Calvin Diep  3 , Hance Clarke  2   3 , Daniel Kapustin  […]

Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010

This originally appeared at https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1898878 October 2014 Marcus A. Bachhuber, MD1,2,3; Brendan Saloner, PhD3,4; Chinazo O. Cunningham, MD, MS5; et alColleen L. Barry, PhD, MPP3,6 JAMA Intern Med. 2014;174(10):1668-1673. doi:10.1001/jamainternmed.2014.4005 Abstract Importance  Opioid analgesic overdose mortality continues to rise in the United States, driven by increases in prescribing for chronic pain. Because chronic pain is a major indication for medical cannabis, laws that establish access to medical cannabis may […]

The medicinal use of cannabis and cannabinoids–an international cross-sectional survey on administration forms

This originally appeared at https://pubmed.ncbi.nlm.nih.gov/24175484/ Abstract Cannabinoids, including tetrahydrocannabinol and cannabidiol, are the most important active constituents of the cannabis plant. Over recent years, cannabinoid-based medicines (CBMs) have become increasingly available to patients in many countries, both as pharmaceutical products and as herbal cannabis (marijuana). While there seems to be a demand for multiple cannabinoid-based […]

Low Dose Vaporized Cannabis Significantly Improves Neuropathic Pain

This originally appeared at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/ Published online 2012 Dec 11. doi: 10.1016/j.jpain.2012.10.009 PMCID: PMC3566631 NIHMSID: NIHMS439212 PMID: 23237736 Barth Wilsey, MD, Thomas D. Marcotte, PhD, Associate Professor, Reena Deutsch, PhD, Statistician, Ben Gouaux, Research Associate, Staci Sakai, Research Associate, and Haylee Donaghe, Research Associate Abstract We conducted a double-blind, placebo-controlled, crossover study evaluating the analgesic efficacy of vaporized cannabis in subjects, the majority of whom were experiencing neuropathic pain despite […]